MONDAY, Nov. 11, 2024 (HealthDay News) — Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports. Heart disease deaths linked to obesity increased 2.8-fold between 1999 and 2020, according to findings presented today at the American Heart Association’s annual meeting inContinue Reading

TUESDAY, Nov. 5, 2024 (HealthDay News) — Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under the Medicaid system, individual states areContinue Reading

FRIDAY, Nov. 1, 2024 (HealthDay News) — The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who received weekly injections of semaglutide — the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy — had a nearly 14%Continue Reading